Recently in this journal, a report by James et al 1 was paired with an editorial by Gladwin and Schechter. 2 However, the invited commentators did not discuss the novel finding of James et al that hemoglobin (Hb) glycosylation in diabetes impairs vasorelaxation by altering nitric oxide (NO) binding to Hb thiols. Instead, the guest editors focused on vascular dilation by red blood cells (RBCs) in the absence of disease, for which they now state that there are "two competing mechanisms." This imposes an unnecessary dichotomy on our emerging understanding of how RBCs dilate blood vessels with NO, as in hypoxic dilation. If the two alternatives in a dichotomy are not the sole alternatives, or are not mutually exclusive, or if neither is true, the dichotomy is false and forces sincere dissenters into extreme points of view, allows the dichotomists to frame the debate improperly, and wastes intellectual resources. All this impedes scientific advance.
